Real-time intraoperative margin assessment
Dr. Jeffrey Falk, board certified Surgical Oncologist at St Johns Hospital in Detroit, recently shared his outstanding results reducing positive margin rates using MarginProbe in lumpectomy at ORBS by Design 2018.
A study recently published in the American Journal of Surgery demonstrates that proper use of Dune Medical Devices’ intraoperative margin assessment device, MarginProbe, results in a significant identification of positive margins and a resulting reduction in the re-excision rate for breast conserving surgery - the standard option for patients with early-stage breast cancer.
A study recently presented during the 2017 American Society of Breast Surgeons annual meeting demonstrates that proper use of Dune Medical Devices’ intraoperative margin assessment device, MarginProbe, results in a significant difference in the total re-excision rate during breast conserving surgery- the standard option for patients with early stage breast cancer.
Obtaining clear margins following a lumpectomy surgery for breast cancer is an important factor in the treatment of breast cancer while conserving the breast (BCS). Historically, high rates, 26%, of surgical interventions to obtain clear margins have been reported1 .
ou want to be up to date